Class information for:
Level 1: CD3 ZETA//ORAL BIOL ORAL MED//ZETA CHAIN

Basic class information
Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
10 4 IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY 1369268
255 3       IMMUNOLOGY//CELLULAR IMMUNOLOGY//JOURNAL OF IMMUNOLOGY 46035
1097 2             INTERLEUKIN 2//OK 432//CANCER IMMUNOLOGY IMMUNOTHERAPY 10078
20825 1                   CD3 ZETA//ORAL BIOL ORAL MED//ZETA CHAIN 468

Terms with highest relevance score


rank Category termType chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 CD3 ZETA authKW 351809 3% 33% 16
2 ORAL BIOL ORAL MED address 292783 2% 43% 10
3 ZETA CHAIN authKW 269354 3% 33% 12
4 TIMM address 240506 1% 71% 5
5 TCR ZETA authKW 206229 1% 44% 7
6 ZETA CHAIN EXPRESSION authKW 202028 1% 100% 3
7 CD3 ZETA CHAIN authKW 142600 1% 35% 6
8 HISTAMINE DIHYDROCHLORIDE authKW 140291 1% 42% 5
9 OSCSCS authKW 134685 0% 100% 2
10 REGULATORY NK authKW 134685 0% 100% 2

Web of Science journal categories


chi_square_rank Category chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 Oncology 3671 46% 0% 216
2 Immunology 2688 37% 0% 171
3 Hematology 330 9% 0% 41
4 Medicine, Research & Experimental 164 8% 0% 38
5 Cell Biology 112 10% 0% 46
6 Urology & Nephrology 27 3% 0% 14
7 Pharmacology & Pharmacy 9 5% 0% 25
8 Pathology 6 2% 0% 8
9 Otorhinolaryngology 4 1% 0% 5
10 Obstetrics & Gynecology 4 2% 0% 8

Address terms


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 ORAL BIOL ORAL MED 292783 2% 43% 10
2 TIMM 240506 1% 71% 5
3 JANE JERRY WEINTRAUB RECONSTRUCT BIOTECHNOL 133271 4% 12% 17
4 SERV CLIN 3 121214 1% 60% 3
5 IMMUNE GENETHER Y 89789 0% 67% 2
6 AMSTERDAM GYNAECOL ONCOL GRP 67343 0% 100% 1
7 AOTO UNIV HOSP 67343 0% 100% 1
8 BIOL THER Y SURG ONCOL PROGRAM 67343 0% 100% 1
9 CARDINAL BERBARDIN CANC 67343 0% 100% 1
10 CHAO FAMILY COMPREHENES CANC 67343 0% 100% 1

Journals


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 CANCER IMMUNOLOGY IMMUNOTHERAPY 17525 7% 1% 34
2 CLINICAL CANCER RESEARCH 3937 6% 0% 30
3 CRITICAL REVIEWS IN ONCOGENESIS 2052 0% 2% 2
4 NATURAL IMMUNITY 1934 0% 1% 2
5 JOURNAL OF IMMUNOTHERAPY 1410 1% 0% 6
6 CYTOKINES AND MOLECULAR THERAPY 1245 0% 2% 1
7 JOURNAL OF IMMUNOLOGY 1239 7% 0% 32
8 INTERNATIONAL JOURNAL OF CANCER 1161 4% 0% 19
9 JOURNAL OF CANCER 1032 1% 0% 4
10 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 948 2% 0% 9

Author Key Words


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass LCSH search Wikipedia search
1 CD3 ZETA 351809 3% 33% 16 Search CD3+ZETA Search CD3+ZETA
2 ZETA CHAIN 269354 3% 33% 12 Search ZETA+CHAIN Search ZETA+CHAIN
3 TCR ZETA 206229 1% 44% 7 Search TCR+ZETA Search TCR+ZETA
4 ZETA CHAIN EXPRESSION 202028 1% 100% 3 Search ZETA+CHAIN+EXPRESSION Search ZETA+CHAIN+EXPRESSION
5 CD3 ZETA CHAIN 142600 1% 35% 6 Search CD3+ZETA+CHAIN Search CD3+ZETA+CHAIN
6 HISTAMINE DIHYDROCHLORIDE 140291 1% 42% 5 Search HISTAMINE+DIHYDROCHLORIDE Search HISTAMINE+DIHYDROCHLORIDE
7 OSCSCS 134685 0% 100% 2 Search OSCSCS Search OSCSCS
8 REGULATORY NK 134685 0% 100% 2 Search REGULATORY+NK Search REGULATORY+NK
9 MAC 1 CELL 89789 0% 67% 2 Search MAC+1+CELL Search MAC+1+CELL
10 MALE ZOOID 89789 0% 67% 2 Search MALE+ZOOID Search MALE+ZOOID

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.

Classes with closest relation at Level 1


rank cluster_id2 link
1 10902 CELLULAR INJURY//TCR ZETA CHAIN//CD3 GAMMA
2 19009 IRX 2//IMMUNE REGRESSION//T CELLS ACTIVATION MARKERS
3 33307 UNITA OPERAT ASSISTENZIALE GINECOL ONCOL//TUMOR DRAINING LYMPH NODES//CANC NEW JERSEY SURG
4 31379 CANCER IMMUNODEFICIENCY//MAINTENANCE IMMUNOTHERAPY//WHOLE BLOOD CELL CULTURES
5 18545 CIMETIDINE//ACTIVE PASSIVE ENHANCEMENT//ARTHUS TYPE HYPERSENSITIVITY
6 23765 IMMUNOL BIOTHER Y PROGRAM//INTERLEUKIN 2//MHC NONRESTRICTED CYTOTOXICITY
7 820 INTERLEUKIN 2//LYMPHOKINE ACTIVATED KILLER CELLS//TUMOR INFILTRATING LYMPHOCYTES
8 5747 MYELOID DERIVED SUPPRESSOR CELLS//MDSC//MDSCS
9 32894 ANGIOGENET//ASBESTOS RELATED DISEASES//AUSTRALIAN MESOTHELIOMA TUMOUR BANK
10 10158 TUMOR VACCINE//ADV CELL MOL THER Y//ALLOGENEIC VACCINATION

Go to start page